Clinical Trials Browser

Phase 3 × INDUSTRY × emicizumab × Clear all

NCT03020160 2023-01-11

HAVEN 4

Phase 3 Completed

48 enrolled 44 charts 1 FDA

Classical hematology

Hemophilia A

NCT02847637 2022-11-16

HAVEN 3

Phase 3 Completed

152 enrolled 46 charts 1 FDA

Classical hematology

Hemophilia A

NCT02622321 2021-06-24

HAVEN 1

Phase 3 Completed

113 enrolled 45 charts 1 FDA

Classical hematology

Hemophilia A

NCT02795767 2021-06-02

HAVEN 2

Phase 3 Completed

88 enrolled 65 charts 1 FDA

Classical hematology

Hemophilia A